Skip to main content
. 2018 Nov 8;8:16548. doi: 10.1038/s41598-018-35036-9

Table 3.

Aqueous cytokine levels at baseline and during the follow-up.

Cytokine (pg/mL) Controls Cases Absolute variation Baseline vs 120 days p-value# p-value*
Baseline 60 days 120 days
Interleukins
      IL-1β 0.06 (0.04; 0.09) 0.17 (0.01; 0.31) 0.10 (0.01; 0.4) 0.04 (0.01; 0.26) −0.10 (−0.09; 0.23) 0.147 0.020
      IL-1RA 3.51 (2.10; 14.35) 3.97 (1.89; 19.58) 2.94 (1.55; 23.05) 0.94 (0.54; 1.74) −2.16 (−4.13; −0.03) 0.685 0.014
      IL-4 1.28 (0.49; 2.51) 0.57 (0.33; 2.37) 0.72 (0.33; 3.89) 0.99 (0.33; 1.65) 0.21 (−2.52; 5.49) 0.334 0.917
      IL-5 0.14 (0.10; 0.41) 0.15 (0.03; 0.24) 0.07 (0.03; 0.23) 0 (0; 0.20) −0.16 (−0.25; −0.03) 0.352 0.013
      IL-6 2.99 (1.25; 6.31) 5.84 (2.10; 24.81) 9.75 (3.81; 19.62) 3.11 (2.15; 11.39) −3.05 (−6.13; 0.37) 0.078 0.050
      IL-7 2.05 (1.43; 3.58) 1.86 (0.70; 4.32) 1.06 (0.70; 2.91) 0.88 (0.29; 2.54) −0.08 (−1.99; 0.30) 0.540 0.441
      IL-10 0.54 (0.16; 0.82) 1.22 (0.08; 1.99) 0.66 (0.02; 2.28) 0.41 (0; 2.16) 0 (−0.31; 0.10) 0.005 0.479
      IL-12p40 3.49 (0.62; 4.78) 398.50 (386.76; 423.30) 123.48 (0.74; 139.78) 218.01 (2.79; 286.01) −196.87 (−396.94; 132.45) <0.001 <0.001
      IL-12p70 2.05 (0.34; 2.39) 89.52 (1.62; 98.35) 9.73 (0.34; 29.21) 12.59 (0.34; 31.35) −81.91 (−98.36; 7.59) <0.001 0.004
      IL-15 1.91 (0.87; 3.59) 4.62 (3.17; 9.88) 2.69 (1.95; 8.91) 5.33 (2.52; 11.51) 1.94 (−4.78; 1.19) <0.001 0.097
      G-CSF 1.11 (0.74; 1.87) 1.23 (0.74; 4.03) 1.40 (0.42; 3.46) 1.16 (0.06; 2.02) −0.88 (−3.89; 0.42) 0.740 0.301
      GM-CSF 0.27 (0.13; 0.54) 0.12 (0.05; 0.23) 0.21 (0.09; 0.37) 0.25 (0.03; 0.43) 0.14 (−0.1; 0.25) 0.350 0.038
GrowthFactors
      EGF 1.48 (0.25; 6.50) 3.28 (1.23; 4.48) 0.88 (0.25; 3.3) 1.26 (0.25; 3.02) −4.55 (−15.83; −1.28) 0.047 0.067
      FGF-2 20.48 (11.65; 395.00) 5.42 (0.28; 8.41) 5.15 (3.50; 12.23) 3.55 (3.50; 12.04) −1.78 (−2.35; 0.11) 0.001 0.717
      VEGF 0.43 (0.12; 0.88) 3.41 (0.91; 10.75) 2.19 (0.40; 7.05) 1.03 (0.40; 3.98) −0.09 (−4.22; 2.48) <0.001 0.027
Interferons
      IFNα2 1.11 (0.86; 5.10) 2.65 (0.18; 8.16) 2.84 (0.18; 7.75) 3.87 (1.07; 4.71) 0.33 (−3.18; 1.41) 0.531 0.457
Chemokines
      MCP-1 707.00 (435.34; 1891.00) 789.00 (0.97; 1399.75) 1262.50 (692.50; 2315.50) 1088.50 (151.00; 3004.00) −78.71 (−282.32; 618.84) 0.451 0.670
      MIP-1α 1.69 (1.69; 2.61) 3.96 (1.34; 8.95) 3.47 (0.65; 6.94) 3.56 (1.58; 6.82) −0.40 (−1.92; 1.72) 0.238 0.273
      MIP-1β 4.77 (1.75; 6.69) 6.48 (1.39; 11.86) 3.53 (0.70; 7.14) 3.23 (0.55; 5.92) −6.92 (−7.81; −4.00) 0.015 0.441
      MCP-3 1.55 (1.06; 3.29) 2.53 (0.65; 4.54) 1.7 (0.16; 4.08) 0.65 (0.06; 2.36) −3.54 (−5.39; −1.31) 0.003 0.078
      EOTAXIN 0.53 (0.42; 5.40) 2.71 (1.79; 6.4) 2.54 (1.40; 5.32) 2.61 (1.06; 13.68) −2.67 (−4.67; 1.53) 0.072 0.034
      MDC 1.43 (1.43; 3.25) 15.56 (4.50; 20.55) 8.75 (3.49; 14.67) 2.68 (1.43; 3.69) −14.71 (−19.84; −3.59) 0.007 0.068
      GRO 21.35 (6.98; 39.31) 26.35 (7.48; 40.21) 29.08 (13.36; 41.23) 17.08 (7.60; 31.88) −12.21 (−21.65; 2.72) 0.896 0.013
      IL-8 4.96 (1.86; 10.12) 4.41 (1.86; 10.63) 7.83 (3.00; 27.53) 7.18 (2.41; 22.98) −1.95 (−6.00; 6.60) 0.370 0.264
      IP-10 166.00 (38.89; 236.00) 292.97 (0.31; 338.50) 151.68 (24.12; 180.10) 48.93 (3.37; 60.75) −175.60 (−300.71; 0) 0.636 0.001
      Fractalkine 8.68 (5.05; 14.33) 16.3 (1.61; 44.88) 30.55 (18.90; 51.76) 27.77 (4.61; 41.21) 2.28 (−4.14; 9.48) 0.494 0.035
      Flt_3L 12.37 (2.73; 19.75) 13.31 (4.23; 17.78) 16.01 (5.07; 18.59) 13.14 (6.10; 20.95) −0.21 (−12.40; 4.81) 0.764 0.002

Cytokine levels are expressed as median and Interquartile range (IQR).

*Friedman test evaluating variation in cytokine levels among time; p < 0.05, p < 0.01 pairwise post-hoc analysis vs previous.

measurement.

Bolded p-value were significant after FDR correction.

#Baseline vs controls.

For same cytokines, the concentration values were at the lowest test sensitivity threshold; therefore exact concentration values are not presented. The excluded cytokines were IL-1α, IL-2, IL-9, TGFα, IFNγ, sCD40L and TNFα.